Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 1/2012

01.01.2012 | Original Article

5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells

verfasst von: Jian-Feng Yang, Jian-Guo Cao, Li Tian, Fei Liu

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

5, 7-dimethoxyflavone (DMF) has been reported to induce apoptosis in various cancer cells. The aim of this study was to examine whether DMF sensitizes human hepatocellular carcinoma (HCC) cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and its mechanism.

Methods

Human hepatocellular carcinoma cell lines Hep3B, Huh-7, and Hep G2 and human embryo liver L-02 cells were cultured in vitro. The cytotoxic activities were determined using MTT assay. The apoptotic cell death was examined using Flow cytometry using PI staining and DNA agarose gel electrophoresis. The activities of caspase-3, caspase-8, and caspase-9 were measured using ELISA. Intracellular ROS was measured by FCM using the fluorescent probe DCHF-DA, and the expression of DR4, DR5, CHOP, GPR78, and ATF4 proteins was analyzed using Western blot.

Results

Our results demonstrated subtoxic concentrations of DMF sensitize HCC cells to TRAIL-induced apoptosis and induce the death receptor 5 (DR5) expression level, accompanying the generation of reactive oxygen species (ROS) and the upregulation of CHOP, GPR78, and ATF4 protein expression. Pretreatment with N-acetylcysteine (NAC) inhibited DMF-induced upregulation of DR5, CHOP, GPR78, and ATF4 protein expression and blocked the cotreatment-induced apoptosis. Furthermore, DMF-mediated sensitization of HCC cells to TRAIL was reduced by administration of a blocking antibody or small interfering RNAs for DR5, salubrinal, an inhibitor of ER stress, and the small interfering RNAs for CHOP. However, DMF could not induce the upregulation of DR5 expression, generation of ROS, and sensitization of TRAIL-induced apoptotic cell death in human embryo liver L-02 cells or normal human peripheral blood mononuclear cells (PBMCs).

Conclusion

The present study demonstrates that DMF selectively enhances TRAIL-induced apoptosis by ROS-stimulated ER-stress triggering CHOP-mediated DR5 upregulation in HCC.
Literatur
1.
Zurück zum Zitat Wicker CA, Sahu RP, Kulkarni-Datar K, Srivastava SK, Brown TL (2010) BITC sensitizes pancreatic adenocarcinomas to TRAIL-induced apoptosis. Cancer Growth Metastasis 2009:45–55PubMed Wicker CA, Sahu RP, Kulkarni-Datar K, Srivastava SK, Brown TL (2010) BITC sensitizes pancreatic adenocarcinomas to TRAIL-induced apoptosis. Cancer Growth Metastasis 2009:45–55PubMed
2.
Zurück zum Zitat Tiwary R, Yu W, Li J, Park SK, Sanders BG et al (2010) Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One 5:e11865PubMedCrossRef Tiwary R, Yu W, Li J, Park SK, Sanders BG et al (2010) Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One 5:e11865PubMedCrossRef
3.
Zurück zum Zitat Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB (2010) Gossypol induces death receptor-5 through activation of ROS-ERK-chop pathway and sensitizes colon cancer cells to trail. J Biol Chem 285:35418–35427PubMedCrossRef Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB (2010) Gossypol induces death receptor-5 through activation of ROS-ERK-chop pathway and sensitizes colon cancer cells to trail. J Biol Chem 285:35418–35427PubMedCrossRef
4.
Zurück zum Zitat Seo SB, Hur JG, Kim MJ, Lee JW, Kim HB et al (2010) TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases. Mol Cancer 9:199PubMedCrossRef Seo SB, Hur JG, Kim MJ, Lee JW, Kim HB et al (2010) TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases. Mol Cancer 9:199PubMedCrossRef
5.
Zurück zum Zitat do Lim Y, Park JH (2009) Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am J Physiol Gastrointest Liver Physiol 296:G1060–G1068CrossRef do Lim Y, Park JH (2009) Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am J Physiol Gastrointest Liver Physiol 296:G1060–G1068CrossRef
6.
Zurück zum Zitat Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J et al (2005) Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Invest Ophthalmol Vis Sci 46:358–366PubMedCrossRef Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J et al (2005) Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Invest Ophthalmol Vis Sci 46:358–366PubMedCrossRef
7.
Zurück zum Zitat Srivastava RK (2001) TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 3:535–546PubMedCrossRef Srivastava RK (2001) TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 3:535–546PubMedCrossRef
8.
Zurück zum Zitat Wang S, El-Deiry WS (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628–8633PubMedCrossRef Wang S, El-Deiry WS (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628–8633PubMedCrossRef
9.
Zurück zum Zitat Ivanov VN, Bhoumik A, Ronai Z (2003) Death receptors and melanoma resistance to apoptosis. Oncogene 22:3152–3161PubMedCrossRef Ivanov VN, Bhoumik A, Ronai Z (2003) Death receptors and melanoma resistance to apoptosis. Oncogene 22:3152–3161PubMedCrossRef
10.
Zurück zum Zitat Ozoren N, Fisher MJ, Kim K, Liu CX, Genin A et al (2000) Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 16:917–925PubMed Ozoren N, Fisher MJ, Kim K, Liu CX, Genin A et al (2000) Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 16:917–925PubMed
11.
12.
Zurück zum Zitat Carr BI (2004) Hepatocellular carcinoma: current management and future trends. Gastroenterology 127:S218–S224PubMedCrossRef Carr BI (2004) Hepatocellular carcinoma: current management and future trends. Gastroenterology 127:S218–S224PubMedCrossRef
13.
Zurück zum Zitat Shankar S, Srivastava RK (2004) Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist Updat 7:139–156PubMedCrossRef Shankar S, Srivastava RK (2004) Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist Updat 7:139–156PubMedCrossRef
14.
Zurück zum Zitat Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K et al (2000) Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 32:482–490PubMedCrossRef Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K et al (2000) Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 32:482–490PubMedCrossRef
15.
Zurück zum Zitat Patanasethanont D, Nagai J, Yumoto R, Murakami T, Sutthanut K et al (2007) Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. J Pharm Sci 96:223–233PubMedCrossRef Patanasethanont D, Nagai J, Yumoto R, Murakami T, Sutthanut K et al (2007) Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. J Pharm Sci 96:223–233PubMedCrossRef
16.
Zurück zum Zitat Wu D, Nair MG, DeWitt DL (2002) Novel compounds from Piper methysticum Forst (Kava Kava) roots and their effect on cyclooxygenase enzyme. J Agric Food Chem 50:701–705PubMedCrossRef Wu D, Nair MG, DeWitt DL (2002) Novel compounds from Piper methysticum Forst (Kava Kava) roots and their effect on cyclooxygenase enzyme. J Agric Food Chem 50:701–705PubMedCrossRef
17.
Zurück zum Zitat Haberlein H, Tschiersch KP, Schafer HL (1994) Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterized by structure activity relationships and in vivo studies of a plant extract. Pharmazie 49:912–922PubMed Haberlein H, Tschiersch KP, Schafer HL (1994) Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterized by structure activity relationships and in vivo studies of a plant extract. Pharmazie 49:912–922PubMed
18.
Zurück zum Zitat Wen X, Walle T (2007) Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. Cancer Lett 246:109–114PubMedCrossRef Wen X, Walle T (2007) Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. Cancer Lett 246:109–114PubMedCrossRef
19.
Zurück zum Zitat Wen X, Walle UK, Walle T (2005) 5, 7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26:803–809PubMedCrossRef Wen X, Walle UK, Walle T (2005) 5, 7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26:803–809PubMedCrossRef
20.
Zurück zum Zitat Wen X, Walle T (2005) Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26:1774–1781PubMedCrossRef Wen X, Walle T (2005) Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26:1774–1781PubMedCrossRef
21.
Zurück zum Zitat Wang CK, Cao JG, Peng B, Gu YX, Zheng GP et al (2010) Inhibition of growth and motility of human A549 lung carcinoma cells by a recombined vascular basement membrane derived peptide. Cancer Lett 292:261–268PubMedCrossRef Wang CK, Cao JG, Peng B, Gu YX, Zheng GP et al (2010) Inhibition of growth and motility of human A549 lung carcinoma cells by a recombined vascular basement membrane derived peptide. Cancer Lett 292:261–268PubMedCrossRef
22.
Zurück zum Zitat Yang XH, Zheng X, Cao JG, Xiang HL, Liu F et al (2010) 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol 16:3385–3393PubMedCrossRef Yang XH, Zheng X, Cao JG, Xiang HL, Liu F et al (2010) 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol 16:3385–3393PubMedCrossRef
23.
Zurück zum Zitat Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P et al (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2:241–243PubMedCrossRef Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P et al (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2:241–243PubMedCrossRef
24.
Zurück zum Zitat Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P et al (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599–609PubMedCrossRef Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P et al (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599–609PubMedCrossRef
25.
Zurück zum Zitat Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ et al (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611–620PubMedCrossRef Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ et al (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611–620PubMedCrossRef
26.
Zurück zum Zitat Benov L, Sztejnberg L, Fridovich I (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25:826–831PubMedCrossRef Benov L, Sztejnberg L, Fridovich I (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25:826–831PubMedCrossRef
27.
Zurück zum Zitat LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227–231PubMedCrossRef LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227–231PubMedCrossRef
28.
Zurück zum Zitat Pellerito O, Calvaruso G, Portanova P, De Blasio A, Santulli A et al (2010) The synthetic cannabinoid WIN 55, 212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis. Mol Pharmacol 77:854–863PubMedCrossRef Pellerito O, Calvaruso G, Portanova P, De Blasio A, Santulli A et al (2010) The synthetic cannabinoid WIN 55, 212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis. Mol Pharmacol 77:854–863PubMedCrossRef
29.
Zurück zum Zitat Jo M, Kim TH, Seol DW, Esplen JE, Dorko K et al (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564–567PubMedCrossRef Jo M, Kim TH, Seol DW, Esplen JE, Dorko K et al (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564–567PubMedCrossRef
30.
Zurück zum Zitat Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB et al (2000) Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 60:553–559PubMed Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB et al (2000) Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 60:553–559PubMed
31.
Zurück zum Zitat Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D et al (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7:383–385PubMedCrossRef Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D et al (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7:383–385PubMedCrossRef
32.
Zurück zum Zitat Qin J, Chaturvedi V, Bonish B, Nickoloff BJ (2001) Avoiding premature apoptosis of normal epidermal cells. Nat Med 7:385–386PubMedCrossRef Qin J, Chaturvedi V, Bonish B, Nickoloff BJ (2001) Avoiding premature apoptosis of normal epidermal cells. Nat Med 7:385–386PubMedCrossRef
33.
Zurück zum Zitat He Q, Huang Y, Sheikh MS (2004) Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells. Oncogene 23:2554–2558PubMedCrossRef He Q, Huang Y, Sheikh MS (2004) Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells. Oncogene 23:2554–2558PubMedCrossRef
34.
Zurück zum Zitat Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS et al (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24:1199–1208PubMedCrossRef Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS et al (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24:1199–1208PubMedCrossRef
35.
Zurück zum Zitat Zou W, Liu X, Yue P, Zhou Z, Sporn MB et al (2004) c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res 64:7570–7578PubMedCrossRef Zou W, Liu X, Yue P, Zhou Z, Sporn MB et al (2004) c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res 64:7570–7578PubMedCrossRef
36.
Zurück zum Zitat Staib F, Hussain SP, Hofseth LJ, Wang XW, Harris CC (2003) TP53 and liver carcinogenesis. Hum Mutat 21:201–216PubMedCrossRef Staib F, Hussain SP, Hofseth LJ, Wang XW, Harris CC (2003) TP53 and liver carcinogenesis. Hum Mutat 21:201–216PubMedCrossRef
37.
Zurück zum Zitat Walle T, Ta N, Kawamori T, Wen X, Tsuji PA et al (2007) Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem Pharmacol 73:1288–1296PubMedCrossRef Walle T, Ta N, Kawamori T, Wen X, Tsuji PA et al (2007) Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem Pharmacol 73:1288–1296PubMedCrossRef
38.
Zurück zum Zitat Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S et al (2008) Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Cancer Res 68:266–275PubMedCrossRef Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S et al (2008) Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Cancer Res 68:266–275PubMedCrossRef
39.
Zurück zum Zitat Lim JH, Park JW, Kim SH, Choi YH, Choi KS et al (2008) Rottlerin induces pro-apoptotic endoplasmic reticulum stress through the protein kinase C-delta-independent pathway in human colon cancer cells. Apoptosis 13:1378–1385PubMedCrossRef Lim JH, Park JW, Kim SH, Choi YH, Choi KS et al (2008) Rottlerin induces pro-apoptotic endoplasmic reticulum stress through the protein kinase C-delta-independent pathway in human colon cancer cells. Apoptosis 13:1378–1385PubMedCrossRef
40.
Zurück zum Zitat Eom KS, Kim HJ, So HS, Park R, Kim TY (2010) Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biol Pharm Bull 33:1644–1649PubMedCrossRef Eom KS, Kim HJ, So HS, Park R, Kim TY (2010) Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biol Pharm Bull 33:1644–1649PubMedCrossRef
Metadaten
Titel
5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells
verfasst von
Jian-Feng Yang
Jian-Guo Cao
Li Tian
Fei Liu
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 1/2012
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-011-1686-9

Weitere Artikel der Ausgabe 1/2012

Cancer Chemotherapy and Pharmacology 1/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.